Regeneron Pharmaceuticals Inc. buy knallfrosch44665
Start price
14.04.24
/
60%
€856.40
Target price
14.04.25
-
Performance (%)
-17.63%
End price
24.11.24
€705.40
Summary
This prediction ended on 24.11.24 with a price of €705.40. The prediction for Regeneron Pharmaceuticals Inc. disappointed with a performance of -17.63%. knallfrosch44665 has 60% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -7.713% | -7.713% | -4.763% |
| iShares Core DAX® | 0.191% | 4.771% | 20.559% |
| iShares Nasdaq 100 | -0.614% | 3.137% | 5.816% |
| iShares Nikkei 225® | 0.599% | 8.016% | 21.913% |
| iShares S&P 500 | -0.036% | 3.593% | 3.588% |
Comments by knallfrosch44665 for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Buy Regeneron Pharmaceuticals Inc.